Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Tarunya Arun

Has grant

University of Warwick

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Recent Grants

Grant: Open

REFINE-MS: A randomised, rater-blind, phase 3 trial to determine the optimal dose frequency of ocrelizumab for patients with relapsing remitting multiple sclerosis using a novel multi-arm multi-stage frequency-optimisation design.

Open Date: 2025-10-01

Close Date: 2030-09-30

Grant: Open

NIHR Senior Clinical and Practitioner Research Award R1

Open Date: 2024-10-01

Close Date: 2029-09-30

Grant: Close

Diagnostic and predictive biomarkers in Neurosarcoidosis and Multiple Sclerosis: A prospective study

Open Date: 2022-01-01

Close Date: 2025-02-01

Articles (19)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Ruth Geraldes

University of Oxford

UNITED KINGDOM

View details

Karim Kreft

Associate Professor in Neurology and Honorary Consultant Neurologist

University of Nottingham

UNITED KINGDOM

View details

James Blackstone

University College London

UNITED KINGDOM

View details

Carolyn Young

Clinical Professor

University of Liverpool

UNITED KINGDOM

View details

Ali Asadipour

Royal College of Art

UNITED KINGDOM

View details

Alasdair Coles

University of Cambridge

UNITED KINGDOM

View details

Pietro Iaffaldano

Associate Professor of Neurology

University of Bari Aldo Moro

ITALY

View details

Claudia A.M. Gandini Wheeler-Kingshott

University College London

UNITED KINGDOM

View details

Claire Rice

Academic , Associate Professor in Neuroinflammation

University of Bristol

UNITED KINGDOM

View details

Benjamin Meir Jacobs

NIHR Academic Clinical Lecturer in Neurology

Queen Mary University of London

UNITED KINGDOM

View details

Alan Chalmers

Professor of Visualisation

University of Warwick

UNITED KINGDOM

View details

Emma Tallantyre

Clinical Reader

Cardiff University

UNITED KINGDOM

View details

Ian Galea

Professor

University of Southampton

UNITED KINGDOM

View details

Guy Laureys

Ghent University Hospital

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tarunya Arun

Research Interests

Explore related searches

Recent Grants

Articles (19)

Hidden in plain sight

The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice

Real-world evaluation of subcutaneous natalizumab in patients with highly active relapsing-remitting multiple sclerosis

Biosimilar rollouts: practice, pitfalls and the importance of effective communication

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial

Rare clinical convergence: pulmonary sarcoidosis with dilated cardiomyopathy and central myopathy

The visual outcome and efficacy of current therapies for neurosarcoidosis with anterior visual pathway involvement: A systemic review.

Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.

Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance

Cladribine tablets coming of age: expert views on the impact of the new label for patients with MS and the NHS

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK

Assessing the landscape and charting paths: UK neurology trainees’ opinions on neuroinflammation subspecialty

Treatment continuation with cladribine at 5 years after initiation in people with multiple sclerosis: A case series and literature review

Influence of Physicians’ Risk Perception on Switching Treatments Between High- Efficacy and Non–high-Efficacy Disease‑modifying Therapies in Multiple Sclerosis

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.

Virtual Flavor: High-Fidelity Simulation of Real Flavor Experiences

Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study

ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK

Progressive cognitive impairment and gait difficulty in a patient with schizophrenia

Collaborators (14)

Ruth Geraldes

Karim Kreft

James Blackstone

Carolyn Young

Ali Asadipour

Alasdair Coles

Pietro Iaffaldano

Claudia A.M. Gandini Wheeler-Kingshott

Claire Rice

Benjamin Meir Jacobs

Alan Chalmers

Emma Tallantyre

Ian Galea

Guy Laureys

Make your next move.